Summit Therapeutics
SMMT
#1887
Rank
C$14.70 B
Marketcap
C$19.75
Share price
-5.97%
Change (1 day)
-32.83%
Change (1 year)

Summit Therapeutics (SMMT) - Net assets

Net assets on the balance sheet as of September 2025 : C$0.26 Billion

According to Summit Therapeutics 's latest financial reports the company has C$0.26 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Summit Therapeutics - Net assets on balance sheet (from 2014 to 2020)

Net assets by year

Year Net assets Change
2024-12-31$C$0.55 B441.35%
2023-12-31$C$0.10 B-40.04%
2022-12-31$C$0.17 B61.92%
2021-12-31$C$0.10 B4.77%
2020-12-31$C$0.10 B
2019-01-31$C$73.31 M-1432.05%
2018-01-31$-C$5.51 Million-23.03%
2017-01-31$-C$7.16 Million-122.35%
2016-01-31$C$31.99 M-26.44%
2015-01-31$C$43.49 M396.32%
2014-01-31$C$8.76 M22.91%
2013-01-31$C$7.12 M19.84%
2012-01-31$C$5.94 M-35.58%
2011-01-31$C$9.23 M-59.25%
2010-01-31$C$22.66 M5.31%
2009-01-31$C$21.51 M-80.04%
2008-01-31$C$0.10 B16.46%
2007-01-31$C$92.55 M95.5%
2006-01-31$C$47.34 M-23.63%
2005-01-31$C$61.98 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Sarepta Therapeutics
SRPT
C$1.80 B 586.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
C$0.30 B 15.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Coherus BioSciences
CHRS
C$0.11 B-54.35%๐Ÿ‡บ๐Ÿ‡ธ USA